Waldenström Macroglobulinemia NFZ — 46 facilities in 41 cities

Waldenström macroglobulinemia is a rare B-cell lymphoma producing excess IgM immunoglobulin. It causes blood hyperviscosity syndrome, anemia, and neuropathy. The NFZ covers hematological diagnostics, chemotherapy, immunochemotherapy, and BTK inhibitor treatment through drug programs. Patients require regular follow-up at a hematology outpatient clinic for ongoing monitoring of disease activity.